MicroRNAs in cancer metastasis: biological and therapeutic implications

被引:29
作者
Sell, Marie C. C. [1 ]
Ramlogan-Steel, Charmaine A. A. [1 ]
Steel, Jason C. C. [1 ]
Dhungel, Bijay P. P. [2 ,3 ]
机构
[1] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld 4701, Australia
[2] Univ Sydney, Gene & Stem Cell Therapy Program Centenary Inst, Camperdown, NSW 2050, Australia
[3] Univ Sydney, Fac Med & Hlth, Camperdown, NSW 2050, Australia
来源
EXPERT REVIEWS IN MOLECULAR MEDICINE | 2023年 / 25卷
关键词
Cancer therapy; cancer; metastasis; microRNA; INHIBITS CELL-PROLIFERATION; BREAST-CANCER; COLORECTAL-CANCER; LUNG-CANCER; TUMOR-SUPPRESSOR; NONCODING RNA; TARGETED THERAPEUTICS; PANCREATIC-CANCER; DOWN-REGULATION; UP-REGULATION;
D O I
10.1017/erm.2023.7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer metastasis is the primary cause of cancer-related deaths. The seeding of primary tumours at a secondary site is a highly inefficient process requiring substantial alterations in the genetic architecture of cancer cells. These alterations include significant changes in global gene expression patterns. MicroRNAs are small, non-protein coding RNAs which play a central role in regulating gene expression. Here, we focus on microRNA determinants of cancer metastasis and examine microRNA dysregulation in metastatic cancer cells. We dissect the metastatic process in a step-wise manner and summarise the involvement of microRNAs at each step. We also discuss the advantages and limitations of different microRNA-based strategies that have been used to target metastasis in pre-clinical models. Finally, we highlight current clinical trials that use microRNA-based therapies to target advanced or metastatic tumours.
引用
收藏
页数:14
相关论文
共 184 条
[1]  
Acunzo Mario, 2015, Adv Biol Regul, V57, P1, DOI 10.1016/j.jbior.2014.09.013
[2]  
Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120
[3]   MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus [J].
Baertsch, M. A. ;
Leber, M. F. ;
Bossow, S. ;
Singh, M. ;
Engeland, C. E. ;
Albert, J. ;
Grossardt, C. ;
Jaeger, D. ;
von Kalle, C. ;
Ungerechts, G. .
CANCER GENE THERAPY, 2014, 21 (09) :373-380
[4]   RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs [J].
Bajan, Sarah ;
Hutvagner, Gyorgy .
CELLS, 2020, 9 (01)
[5]   miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner [J].
Bandi, Nora ;
Vassella, Erik .
MOLECULAR CANCER, 2011, 10
[6]   MicroRNA as tools and therapeutics in lung cancer [J].
Barger, Jennifer F. ;
Nana-Sinkam, S. Patrick .
RESPIRATORY MEDICINE, 2015, 109 (07) :803-812
[7]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[8]   The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics [J].
Bautista-Sanchez, Diana ;
Arriaga-Canon, Cristian ;
Pedroza-Torres, Abraham ;
De La Rosa-Velazquez, Inti Alberto ;
Gonzalez-Barrios, Rodrigo ;
Contreras-Espinosa, Laura ;
Montiel-Manriquez, Rogelio ;
Castro-Hernandez, Clementina ;
Fragoso-Ontiveros, Veronica ;
Maria Alvarez-Gomez, Rosa ;
Herrera, Luis A. .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 20 :409-420
[9]   Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors [J].
Beg, Muhammad S. ;
Brenner, Andrew J. ;
Sachdev, Jasgit ;
Borad, Mitesh ;
Kang, Yoon-Koo ;
Stoudemire, Jay ;
Smith, Susan ;
Bader, Andreas G. ;
Kim, Sinil ;
Hong, David S. .
INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) :180-188
[10]   Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo [J].
Biscans, Annabelle ;
Coles, Andrew ;
Haraszti, Reka ;
Echeverria, Dimas ;
Hassler, Matthew ;
Osborn, Maire ;
Khvorova, Anastasia .
NUCLEIC ACIDS RESEARCH, 2019, 47 (03) :1082-1096